Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Forte Biosciences, Inc. (FBRX) Non-Current Assets (2016 - 2020)

Forte Biosciences (FBRX) has disclosed Non-Current Assets for 5 consecutive years, with $1.1 million as the latest value for Q3 2020.

  • On a quarterly basis, Non-Current Assets fell 90.07% to $1.1 million in Q3 2020 year-over-year; TTM through Sep 2020 was $5.6 million, a 86.78% decrease, with the full-year FY2019 number at $152000.0, down 97.15% from a year prior.
  • Non-Current Assets was $1.1 million for Q3 2020 at Forte Biosciences, up from $167000.0 in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $13.0 million in Q1 2019 to a low of $152000.0 in Q4 2019.
  • A 5-year average of $4.3 million and a median of $3.4 million in 2016 define the central range for Non-Current Assets.
  • Peak YoY movement for Non-Current Assets: surged 704.38% in 2019, then tumbled 98.66% in 2020.
  • Forte Biosciences' Non-Current Assets stood at $2.9 million in 2016, then tumbled by 50.03% to $1.4 million in 2017, then soared by 269.32% to $5.3 million in 2018, then plummeted by 97.15% to $152000.0 in 2019, then soared by 632.24% to $1.1 million in 2020.
  • Per Business Quant, the three most recent readings for FBRX's Non-Current Assets are $1.1 million (Q3 2020), $167000.0 (Q2 2020), and $4.1 million (Q1 2020).